LONA - Athira Pharma, Inc.
5.3
-0.070 -1.321%
Share volume: 12,517
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$5.37
-0.07
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-01-2024 | 11-07-2024 | 02-27-2025 | 05-09-2025 | 11-06-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 27.687 M | 28.028 M | 25.494 M | 15.566 M | 9.536 M | 6.874 M | |
| Selling general and admin | 6.451 M | 5.874 M | 7.572 M | 6.196 M | 5.234 M | 4.049 M | |
| Research and development | 21.236 M | 22.154 M | 17.922 M | 9.370 M | 4.302 M | 2.825 M | |
| Total expenses | 27.687 M | 28.028 M | 29.621 M | 15.566 M | 9.536 M | 6.874 M | |
| 1.23% | 5.68% | -47.45% | -38.74% | -27.92% | |||
| Operating income | -27.687 M | -28.028 M | -29.621 M | -15.566 M | -9.536 M | -6.874 M | |
| Ebit | -27.687 M | -28.028 M | -29.621 M | -15.566 M | -9.143 M | -6.874 M | |
| Pretax income | -27.687 M | -28.028 M | -29.621 M | -15.566 M | -9.143 M | -6.874 M | |
| 1.23% | 5.68% | -47.45% | -41.26% | -24.82% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -26.337 M | -26.859 M | -28.741 M | -15.003 M | -9.143 M | -6.611 M | |
| -1.98% | -7.01% | 47.80% | 39.06% | 27.69% |